Leading Aulos Bioscience's "Triumvirate" Model
Aulos Bioscience hopes to leverage its unique business model, engineered by a VC firm and an Israeli biotech, to develop better treatments for solid...
Stay updated with breaking news from Ben Comer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Aulos Bioscience hopes to leverage its unique business model, engineered by a VC firm and an Israeli biotech, to develop better treatments for solid...
Martin Mackay’s journey from Pfizer executive to founding and leading a rare disease biotech is a reflection of the industry’s evolution...
Fortress Biotech CEO Lindsay Rosenwald talks up Fortress Biotech’s business model, which leverages partner companies to develop promising but...
As the established indications in dermatology become saturated with competing products, a variety of companies, from start-ups to oncology players,...
Amarin is deploying a global strategy to expand patient access to Vascepa, hoping to make up for lost revenues in the U.S.